Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Variants of CITED2 Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification. | J Cardiovasc Dev Dis | 2022 | 36286273 | PubTator, text mining | PubMed |
| Biomarker-based approach to determine etiology and severity of pulmonary hypertension: Focus on microRNA. | Front Cardiovasc Med | 2022 | 36277769 | PubTator, text mining | PubMed |
| Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma. | Nat Commun | 2022 | 36272974 | PubTator, text mining | PubMed |
| Long non-coding RNA ERVK13-1 aggravates osteosarcoma through the involvement of microRNA-873-5p/KLF5 axis. | Acta Biochim Pol | 2022 | 36272150 | PubTator, text mining | PubMed |
| Krüppel-like factor 5 promotes the progression of oral squamous cell carcinoma via the baculoviral IAP repeat containing 5 gene. | Ann Transl Med | 2022 | 36267746 | PubTator, text mining | PubMed |
| The role of hepatocyte nuclear factor 4α (HNF4α) in tumorigenesis. | Front Oncol | 2022 | 36249028 | PubTator, text mining | PubMed |
| miR-124-3p sabotages lncRNA MALAT1 stability to repress chondrocyte pyroptosis and relieve cartilage injury in osteoarthritis. | J Orthop Surg Res | 2022 | 36243708 | PubTator, text mining | PubMed |
| Overview on hydrogen sulfide-mediated suppression of vascular calcification and hemoglobin/heme-mediated vascular damage in atherosclerosis. | Redox Biol | 2022 | 36240620 | PubTator, text mining | PubMed |
| Mechanism and strategies of immunotherapy resistance in colorectal cancer. | Front Immunol | 2022 | 36238278 | PubTator, text mining | PubMed |
| Nutritional Composition and Bioactive Compounds of Native Brazilian Fruits of the Arecaceae Family and Its Potential Applications for Health Promotion. | Nutrients | 2022 | 36235663 | PubTator, text mining | PubMed |
| The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review. | Int J Mol Sci | 2022 | 36233313 | PubTator, text mining | PubMed |
| Emerging Roles of the α-Catenin Family Member α-Catulin in Development, Homeostasis and Cancer Progression. | Int J Mol Sci | 2022 | 36233261 | PubTator, text mining | PubMed |
| STAT3 and Its Pathways' Dysregulation-Underestimated Role in Urological Tumors. | Cells | 2022 | 36230984 | PubTator, text mining | PubMed |
| Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells. | Cells | 2022 | 36230903 | PubTator, text mining | PubMed |
| CircKIF4A Is a Prognostic Factor and Modulator of Natural Killer/T-Cell Lymphoma Progression. | Cancers (Basel) | 2022 | 36230873 | PubTator, text mining | PubMed |
| LncRNA SNHG1 Facilitates Tumor Proliferation and Represses Apoptosis by Regulating PPARγ Ubiquitination in Bladder Cancer. | Cancers (Basel) | 2022 | 36230661 | PubTator, text mining | PubMed |
| Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach. | Cancers (Basel) | 2022 | 36230614 | PubTator, text mining | PubMed |
| The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition. | Mol Cancer | 2022 | 36224562 | PubTator, text mining | PubMed |
| Exosomes: mediators regulating the phenotypic transition of vascular smooth muscle cells in atherosclerosis. | Cell Commun Signal | 2022 | 36221105 | PubTator, text mining | PubMed |
| Pseudogene UBE2MP1 derived transcript enhances in vitro cell proliferation and apoptosis resistance of hepatocellular carcinoma cells through miR-145-5p/RGS3 axis. | Aging (Albany NY) | 2022 | 36214767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=40